BGI Tech Solutions (Poland)sp. z o.o.
Research and experimental development on biotechnology
Overview
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2023 – the filing deadline has passed. 2 of 2 financial statements were filed late (the longest delay 767 days for 2022).
- 2023not filed
- 202220/08/2025
- 202127/11/2023
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2022.
Results vs industry
Industry
Public procurement
BGI Tech Solutions (Poland) is the contractor in 6 public sector contracts, worth USD 18.76k in total. They were signed with 4 public buyers.
| Signed on | Subject | Amount | Public buyer | |
|---|---|---|---|---|
| Oct 21, 2026 | NGS sequencing service | $4,599 | Inlife Instytut Rozrodu Zwierząt i Badań Żywności Polskiej Akademii Nauk | |
| Oct 20, 2026 | Isolation of microbiome DNA from mouse intestinal tissues and host DNA from testicular tissue. Library preparation, metagenomic sequencing of intestinal tissues and whole-genome sequencing of testes, and bioinformatics analysis | $9,186 | Instytut Genetyki I Biotechnologii Zwierząt Polskiej Akademii Nauk | |
| Oct 2, 2026 | Sequencing of 4 mRNA samples of buckwheat Fagopyrum tataricum. Samples QC+stranded mRNA library prep+30M PE clean reads(9G clean data). | $373.34 | Uniwersytet Śląski w Katowicach |
Authorized Representatives
Manner of representation
Declarations of will on behalf of the company require the joint action of two members of the management board, or one member of the management board jointly with a commercial proxy. In the case of a one-person management board, the sole member of the management board is authorised to submit declarations of will on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Bgi Tech Solutions (europe) Cooperatief U.a. | 257,500 | $6,955,699.62 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2021-03-03.
- 93 2620 0006 0000 0000 0000 1542
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| FamicordtxS.A. | $1,365,068.41 | famicordtx.com | ||
| Orphinic ScientificS.A. | $518,429.97 | orphinic.com | ||
| Proper Medical Writingsp. z o.o. | $464,661.64 | propermedicalwriting.com | ||
| Medicofarma BiotechS.A. | $314,882.33 | medicofarmabiotech.pl | ||
| Explorna Therapeuticssp. z o.o. | $304,662.00 | explorna.com | ||
| Frontline BiosciencesS.A. | $219,186.29 | frontlinebiosciences.com | ||
| AI Corelabsp. z o.o. | $128,365.55 | aicorelab.com | ||
| ModicaP.S.A. | $103,400.72 | modica.bio | ||
| WPD Pharmaceuticalssp. z o.o. | $90,822.78 | wpdpharmaceuticals.com | ||
| WPD PharmaceuticalsS.A. | $87,561.70 | wpdpharmaceuticals.pl |
Change history
| Date | Event | |
|---|---|---|
| 2026-07-17 | Share capital increase (450,000.00 PLN → 25,750,000.00 PLN) | |
| 2021-09-20 | Entered in the register |
FAQ
Last updated: 2026-07-17